Drugs / Deqularum
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04067531 | Aug 2020 → Aug 2021 | bacterial infectious disease | Skaraborg Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Deqularum | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04067531 ↗ |
| Known as | deqularum cloride | “The hypoteses is that deqularum cloride takes away the biofilm so that clindamycin will kills the bacteria.” NCT04067531 ↗ |